We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
-1.49%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$1.38B
AUM Growth
-$139M
Cap. Flow
-$105M
Cap. Flow %
-7.62%
Top 10 Hldgs %
10.8%
Holding
1,026
New
99
Increased
30
Reduced
127
Closed
96

Sector Composition

Rank Sector Weight
1 Financials 67.24%
2 Technology 9.48%
3 Healthcare 9.22%
4 Industrials 4.19%
5 Consumer Discretionary 2.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACII
26
DELISTED
Atlas Crest Investment Corp. II
ACII
$7.81M 0.57%
795,875
VPCB
27
DELISTED
VPC Impact Acquisition Holdings II Class A ordinary shre
VPCB
$7.66M 0.56%
781,576
YTPG
28
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$7.63M 0.55%
783,771
FRW
29
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
$7.36M 0.54%
754,145
JWSM
30
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$7.32M 0.53%
744,240
FINM
31
DELISTED
Marlin Technology Corporation Class A Ordinary Share
FINM
$7.22M 0.53%
729,463
STRE
32
DELISTED
Supernova Partners Acquisition Company III, Ltd.
STRE
$7.01M 0.51%
717,080
ASZ
33
DELISTED
Austerlitz Acquisition Corporation II
ASZ
$6.95M 0.51%
713,059
PSAG
34
DELISTED
Property Solutions Acquisition Corporation II Class A Common Stock
PSAG
$6.85M 0.5%
700,000
DTIL icon
35
Precision BioSciences
DTIL
$181M
$6.8M 0.49%
+141,716
New +$8.32M
AVAC
36
DELISTED
Avalon Acquisition Inc. Class A Common Stock
AVAC
$6.76M 0.49%
677,175
KSI
37
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
$6.46M 0.47%
660,998
GBBK
38
DELISTED
Global Blockchain Acquisition Corp. Common Stock
GBBK
$6.16M 0.45%
+625,000
New +$6.13M
CLOE
39
DELISTED
Clover Leaf Capital Corp. Class A Common Stock
CLOE
$6.08M 0.44%
600,425
PDOT
40
DELISTED
Peridot Acquisition Corp. II
PDOT
$6.03M 0.44%
614,754
CHAA
41
DELISTED
Catcha Investment Corp
CHAA
$6.02M 0.44%
613,467
XPOA
42
DELISTED
DPCM Capital, Inc.
XPOA
$6.01M 0.44%
606,049
+179,725
+42% +$1.78M
AONC
43
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$5.99M 0.44%
612,736
FVIV
44
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
$5.99M 0.44%
613,114
VEEA
45
Veea Inc
VEEA
$8.07M
$5.98M 0.44%
610,553
FGMC
46
DELISTED
FG Merger Corp. Common Stock
FGMC
$5.97M 0.43%
+600,000
New +$5.98M
AISP
47
Airship AI Holdings
AISP
$60.6M
$5.93M 0.43%
603,013
CRZN
48
DELISTED
Corazon Capital V838 Monoceros Corp Class A Ordinary Shares
CRZN
$5.93M 0.43%
606,343
FLYA
49
DELISTED
SOAR Technology Acquisition Corp.
FLYA
$5.89M 0.43%
579,538
LGAC
50
DELISTED
Lazard Growth Acquisition Corp. I Ordinary Shares
LGAC
$5.87M 0.43%
600,000

Similar funds

CVI Holdings's Q2 2022 Portfolio in Review

As of Q2 2022, CVI Holdings held 1,026 positions worth $1.38B, down 9.2% from $1.51B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

CVI Holdings withdrew a net $105M in Q2 2022, closing 96 positions and reducing 127 holdings. Its most notable exit was Spring Valley Acquisition Corp. Class A Ordinary Share, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 67% of assets, up from 61% a quarter earlier, followed by Technology and Healthcare.

Against the trend, CVI Holdings opened a new position in Seres Therapeutics worth $9.34M.

  • CVI Holdings's largest Q2 2022 buy was Seres Therapeutics: 136,141 shares worth $9.34M.
  • CVI Holdings added most to Ares Acquisition Corporation in Q2 2022, an estimated $2.45M increase.
  • CVI Holdings's biggest Q2 2022 reduction was 2seventy bio, cutting an estimated $9.41M.
  • CVI Holdings fully exited Spring Valley Acquisition Corp. Class A Ordinary Share in Q2 2022, selling an estimated $18.3M.
  • CVI Holdings's ten largest holdings make up 11% of its $1.38B portfolio in Q2 2022.
  • CVI Holdings opened 99 new positions and closed 96 in Q2 2022.
  • CVI Holdings's portfolio value fell 9.2% quarter-over-quarter to $1.38B.

Based on CVI Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.